Psychedelics: The Paradigm-Changing Future of Mental Health

{
  "id": "PP1162898",
  "track": "Health",
  "focus_area": null,
  "category": "Panel",
  "event_id": "PP1162898",
  "event_type": "panel",
  "format": "Panel",
  "genre": null,
  "subgenre": null,
  "name": "Psychedelics: The Paradigm-Changing Future of Mental Health",
  "presented_by": "Real Chemistry",
  "publish_at": "2026-01-20T15:26:00.000-06:00",
  "reservable": true,
  "reservable_id": "PP1162898",
  "reserved": false,
  "date": "2026-03-16",
  "end_time": "2026-03-16T17:00:00.000-05:00",
  "start_time": "2026-03-16T16:00:00.000-05:00",
  "message": null,
  "image": null,
  "credentials": [
    {
      "name": "Music Badge",
      "type": "music"
    },
    {
      "name": "Platinum Badge",
      "type": "platinum"
    },
    {
      "name": "Innovation Badge",
      "type": "innovation"
    },
    {
      "name": "Film & TV Badge",
      "type": "filmtv"
    }
  ],
  "contributors": [
    {
      "id": 82212,
      "company": "Compass Pathways",
      "credential_types": [
        "filmtv",
        "innovation",
        "music"
      ],
      "entity_id": 2243886,
      "name": "Steve Levine",
      "speaker_types": [],
      "title": "Chief Patient Officer",
      "image": null,
      "speaker_type": "Speaker",
      "details": "Dr. Levine is a board-certified psychiatrist who has spent his career working to improve people’s lives through creating access to innovation in healthcare. Dr. Levine completed internship and residency in psychiatry at New York – Presbyterian Hospital / Weill Cornell Medical Center. He then completed fellowship subspecialty training in psychosomatic medicine / psycho-oncology at Memorial Sloan Kettering Cancer Center/New York – Presbyterian Hospital. Prior to Compass, he founded Actify Neurotherapies in 2010 that built new models of care delivery across the US for interventional psychiatry treatments. He has published in peer-reviewed journals, presented to professional and lay audiences around the world, served in leadership roles, and received awards for leadership and service.",
      "links": {},
      "type": "person"
    },
    {
      "id": 82211,
      "company": "Mental Health America",
      "credential_types": [
        "filmtv",
        "innovation",
        "music"
      ],
      "entity_id": 2243885,
      "name": "Jessica Jackson",
      "speaker_types": [],
      "title": "Vice President, Alliance Development",
      "image": {
        "alt_text": "Jessica Jackson",
        "credit": null,
        "url": "https://images.sxsw.com/_6xgxeO5yIcug0FnUWNcNUW3c0Q=/600x600/images.sxsw.com/48/ea138a32-3553-61f2-1767-6e79d7a02dde/pcid-1098335"
      },
      "speaker_type": "Speaker",
      "details": "Dr. Jessica Jackson leads relationship-building and information exchange with external health-related partners in her role at Mental Health America. She is a licensed psychologist with over a decade of experience spanning startups, hospitals, nonprofits, and the United Nations. A former assistant professor of psychiatry, Dr. Jackson brings academic rigor to real-world challenges. Her research focus has been on dismantling barriers to treatment for underserved populations through inclusive, tech-enabled solutions.",
      "links": {},
      "type": "person"
    },
    {
      "id": 82210,
      "company": "Neuronetics/Greenbrook Wellness Centers",
      "credential_types": [
        "filmtv",
        "innovation",
        "music"
      ],
      "entity_id": 2243884,
      "name": "Geoffrey Grammer",
      "speaker_types": [],
      "title": "Chief Medical Officer",
      "image": {
        "alt_text": "Geoffrey Grammer",
        "credit": null,
        "url": "https://images.sxsw.com/en6eFM6vyCMEqfVxrQtDOr1r2L0=/600x600/images.sxsw.com/48/f58d668d-7fed-4163-c36b-bd4e62549da1/pcid-1632342"
      },
      "speaker_type": "Speaker",
      "details": "Dr. Geoffrey Grammer, M.D. is a psychiatrist and a pioneering trailblazer in mental healthcare.  As Chief Medical Officer at Neuronetics and Greenbrook Mental Wellness Centers, he’s leading the way with breakthrough therapies like transcranial magnetic stimulation (TMS) and nasal esketamine for treatment-resistant depression.  Dr. Grammer is passionate about making mental healthcare more effective, more personalized, and more accessible so patients can find real relief and start feeling like themselves again.",
      "links": {},
      "type": "person"
    },
    {
      "id": 2446,
      "company": "US Medicaid Program",
      "credential_types": [
        "filmtv",
        "innovation",
        "music"
      ],
      "entity_id": 5610,
      "name": "Andrey Ostrovsky",
      "speaker_types": [],
      "title": "Former Chief Medical Officer",
      "image": {
        "alt_text": "Andrey Ostrovsky",
        "credit": null,
        "url": "https://images.sxsw.com/RYsl-J3ezQNhvopJ64MkonerOkQ=/600x600/images.sxsw.com/48/2deaa966-91b7-fa36-f31e-7978257d239c/pcid-776254"
      },
      "speaker_type": "Speaker",
      "details": "Dr. Andrey Ostrovsky is a physician, innovator, and health system reformer who has worked across the frontlines of care delivery and policy. He served as Chief Medical Officer for the U.S. Medicaid program, where he led initiatives to make the nation’s largest health program more responsive and efficient. He also co-founded Care at Hand, a predictive analytics startup acquired by Mindoula Health, and now invests in and advises ventures and nonprofits through Social Innovation Ventures. Having led teams in public health departments, WHO, and legislative offices, Dr. Ostrovsky bridges policy, technology, and clinical practice in his work.",
      "links": {},
      "type": "person"
    }
  ],
  "venue": {
    "accessible": false,
    "age_policy": null,
    "floor": "2",
    "id": "V1703",
    "indoor_outdoor": "INDOOR",
    "name": "Topaz Ballroom 1-3",
    "parent_id": "V1700",
    "parent_venue_name": "The LINE",
    "venue_entry_info": null,
    "formats": null,
    "location": {
      "address": "111 E Cesar Chavez St.",
      "lat_lon": [
        30.2626651,
        -97.7436224
      ],
      "city": "Austin",
      "postal_code": "78701",
      "state": "TX",
      "name": "The LINE"
    },
    "root": {
      "accessible": null,
      "age_policy": null,
      "floor": null,
      "id": "V1700",
      "indoor_outdoor": "INDOOR",
      "name": "The LINE",
      "parent_id": null,
      "parent_venue_name": null,
      "venue_entry_info": null,
      "formats": null
    },
    "events": "[omitted 5 venue events]"
  },
  "description": "Psychedelic treatments are rapidly moving from research into clinical practice, signaling a potential transformation in how we treat mental health conditions. This session will explore how clinical innovation, care delivery models, and advocacy are converging to reshape mental health care safely and effectively for the millions who need better options. Attendees will gain insight into the steps required to bring psychedelic treatments into clinical settings, what patient access can look like, and how providers are navigating the evolving landscape as these treatments enter mainstream care.",
  "experience_level": "Advanced",
  "accessibility": [],
  "accessible_venue": false,
  "add_bcl_url": false,
  "add_slido": false,
  "age_policy": null,
  "american_sign_language": false,
  "apple_url": null,
  "audio_description": false,
  "caption_url": null,
  "closed_captioned": false,
  "cpe_credit": false,
  "has_subtitles": false,
  "hash_tags": [],
  "high_sensory_experience": false,
  "live": false,
  "long_description": "Psychedelic treatments are rapidly moving from research into clinical practice, signaling a potential transformation in how we treat mental health conditions. This session will explore how clinical innovation, care delivery models, and advocacy are converging to reshape mental health care safely and effectively for the millions who need better options. Attendees will gain insight into the steps required to bring psychedelic treatments into clinical settings, what patient access can look like, and how providers are navigating the evolving landscape as these treatments enter mainstream care.",
  "meeting_url": null,
  "meeting_url_live": false,
  "mentorly_url": null,
  "mobile_audio_url": null,
  "open_captioned": false,
  "playlist_tag": null,
  "rebroadcast": false,
  "recommended_ids": [],
  "search_conversions": null,
  "short_program": false,
  "slido_url": null,
  "sort": "PSYCHEDELICS: THE PARADIGM-CHANGING FUTURE OF MENTAL HEALTH",
  "source": "Official",
  "squad_up_url": null,
  "stream_embed": null,
  "stream_id": null,
  "stream_url": null,
  "strobe_warning": false,
  "subdiscipline": null,
  "summit": null,
  "summit_display_name": null,
  "tags": [],
  "talent_attending": null,
  "title_only": false,
  "track_display_name": "Health",
  "trailer_id": null,
  "trailer_url": null,
  "video_on_demand": null,
  "vimeo_id": null,
  "vod": false,
  "xr_project_type": null,
  "youtube_id": null,
  "related_sales_client": null
}